NeuroBioMat

NBM is a Deep Tech company developing a breakthrough solution to treat lesions of the spinal cord at the chronic stage of injury in paraplegic patients

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Archamps, France
  • Currency EUR
  • Founded November 2018
  • Employees 2
  • Incorporation Type Not Incorporated
  • Website N

Company Summary

NBM developed an innovative device for the repair of the spinal cord where there is a true clinical need for a fast-growing market of billion value. The product is fully developed and the technical POC demonstrated. NBM has received positive feedback according to a US/Europe market survey. NBM and is currently looking for € 600K primarily for the industrialization/production, PCT patent extension, Adm-HR, regulatory/legal, clinical documentation

Team

  • Stéphane Woerly
    Founding Président , CSO/CMO

    Doctor of medicine completed by a DEA in Neurochemistry (Louis Pasteur University in Strasbourg). Holds a PhD in Neuroscience from Laval University in Canada. Specialist in the design and evaluation of biomaterials for tissue engineering of the nervous system. Inventor of Neurogel, the first hydrogel device for restorative neurotechnology. Founded the medical biotechnology company Organogel in Canada.

  • Olivier BENOIT
    associate, co-founder,

    Engineer (INSA Lyon) in production in the biomedical industry. Production director of implants for ophthalmic surgery at CORNEAL. Co-founder of ANTEIS, a company specializing in hyaluronic acid-based medical devices for aesthetic medicine, surgical ophthalmology and orthopedics. Was design manager, quality and regulatory affairs director, COO / CTO.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free